Question 1

What is the catalog number for Human Monoclonal IL-7R alpha/CD127 Antibody (lusvertikimab) [DyLight 405]?

Accepted Answer

The catalog number for Human Monoclonal IL-7R alpha/CD127 Antibody (lusvertikimab) [DyLight 405] is NBP3-28021V.

Question 2

What sizes are available for Human Monoclonal IL-7R alpha/CD127 Antibody (lusvertikimab) [DyLight 405]?

Accepted Answer

Human Monoclonal IL-7R alpha/CD127 Antibody (lusvertikimab) [DyLight 405] is available in the following size(s): 0.1 mL.

Question 3

Is Human Monoclonal IL-7R alpha/CD127 Antibody (lusvertikimab) [DyLight 405] in stock?

Accepted Answer

Human Monoclonal IL-7R alpha/CD127 Antibody (lusvertikimab) [DyLight 405] is currently made to order / not held in immediate stock. Contact us for lead time.

Question 4

Is this product species cross-reactive?

Accepted Answer

Cross-reactivity data, based on available testing, is listed under the reactivity section of the datasheet. Contact us if you need reactivity confirmed for a species not listed.

Question 5

Is there an additional fee for hazardous or dry ice shipping of this product?

Accepted Answer

Yes, if this product requires dry ice or is classed as hazardous for transport, the additional fee will be explicitly shown in your quotation before you confirm the order, so there are no surprise charges later.

Question 6

How many freeze-thaw cycles can this product tolerate?

Accepted Answer

We recommend aliquoting the product upon receipt to avoid repeated freeze-thaw cycles, which can reduce activity and stability. This is your responsibility once the product has been delivered.

Human Monoclonal IL-7R alpha/CD127 Antibody (lusvertikimab) [DyLight 405]

Product Specifications

Frequently Asked Questions

Explore Other Products

Anti-CHRNA5 Rabbit Monoclonal Antibody, Carrier-free

Anti-SHCBP1L Antibody Picoband®, Cy3 Conjugate

Tyrosinase (Melanoma Marker) (TYR/2024R), CF647 conjugate, 0.1mg/mL

CD11c (HC1/1), CF405S conjugate, 0.1mg/mL

Anti-PBP/PEBP1 Antibody Picoband® (Dylight488 Conjugate)

OX40 / CD134/ TNFRSF4 (Immuno-Oncology Target) (OX40/3108), 0.2mg/mL